News | October 4, 2010

Beckman Coulter Exhibits Total Lab Solutions At The 2010 World Stem Cell Summit

Beckman

Expanded Portfolio for Core Labs Detailed at Expert Luncheons

Beckman Coulter, Inc. continues its tradition of displaying current and upcoming laboratory solutions at the World Stem Cell Summit, which is being held at the Marriott Renaissance Center in Detroit, Mich., October 4-6. Visitors to Booth 24 will see the latest in analyzers and services designed to optimize productivity and workflow efficiency.

Broad cellular analysis and regenerative medicine portfolios will allow Beckman Coulter to feature more ways to streamline lab performance than ever, with an emphasis on complete laboratory solutions. Featured new and upcoming products will include:

  • The Quantum Cell Expansion System, a closed, automated system for cell expansion.
  • The GenomeLab GeXP Genetic Analysis System.
  • The Multisizer 4 particle sizing and counting system.
  • Kaluza software for multiparametric analysis in flow cytometry.
  • The Gallios multicolor flow cytometer displaying Kaluza software v1.1.
  • The CompuCyte iCys Research Imaging System with iGeneration software.

"Beckman Coulter's experience and current product portfolio are focused on solutions that help to standardize and optimize bioprocess methods and applications in order to reduce analysis time, improve quality and enhance the overall performance of the laboratory," said Brad Calvin, vice president and general manager, Flow Cytometry Business Center at Beckman Coulter. "Our expanded portfolio offers complete and comprehensive solutions for today's cellular therapy research workflows."

Three "Luncheon with the Experts" sessions hosted by Beckman Coulter will provide attendees with the opportunity to learn how they may benefit from the analytical and workflow capabilities of the new systems.

Defining Pluripotency with Multiplex Gene Expression will focus on the utilization of gene expression profiles to effectively characterize and define fully reprogrammed human iPSCs derived from somatic cells.

Optimizing, Automating and Standardizing Cell Therapy Research Workflows offers attendees strategies for standardization and enhanced optimization of bioprocessing and analysis techniques.

Characterizing Embryoid Bodies with the Coulter Principle will cover key features of the Coulter Principle and best practices for its use with stem cells, along with a brief review of recent publications implementing the Coulter Principle for characterizing embryoid bodies.

As a proud sponsor of the 2010 World Stem Cell Summit, Beckman Coulter is offering $100 discount registration passes to our partners and customers who are attending the event. For more information, visit www.coulterflow.com/worldstemcellreport.html

About Beckman Coulter
Beckman Coulter, Inc., based in Orange County, California, develops, manufactures and markets products that simplify, automate and innovate complex biomedical tests. This year marks the company's 75th anniversary of advancing healthcare. More than 200,000 Beckman Coulter systems operate in laboratories around the world, supplying critical information for improving patient health and reducing the cost of care. Recurring revenue, consisting of consumable supplies (including reagent test kits), service and operating-type lease payments, represents about 80 percent of the company's 2009 revenue of $3.3B. For more information, visit www.beckmancoulter.com or www.beckmancoulter.com/75years.

SOURCE: Beckman Coulter, Inc.